The South America cardiopulmonary oxygenator market was valued at US$ 44.13 million in 2022 and is expected to reach US$ 53.49 million by 2028. It is estimated to register a CAGR of 3.3 % from 2022 to 2028.
According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.
Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.
Increasing Surgical Procedures with Surging in Aging Population is Fueling South America Cardiopulmonary Oxygenator Market
Surgical procedures are necessary for managing health conditions such as cardiovascular diseases and lung disorders. In some medical cases, no alternative works without surgery. The high demand for cardiovascular surgeries can be attributed to the increase in the incidence of cardiovascular diseases in the aging population. Further, lung transplantation may be the only helpful treatment option for patients experiencing serious lung damage and non-resolving COVID-19-associated respiratory failure. Thus, with the growing number of cardiovascular and lung transplant surgeries, the demand for cardiopulmonary oxygenators is also on the rise in the region.According to the WHO, the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. Cardiovascular diseases continue to be the leading cause of death among adults over the age of 65. Aging can cause changes in the heart and blood vessels, increasing the risk of developing these diseases. Therefore, the prevalence of cardiovascular diseases among geriatric populations is contributing to the growth of the cardiopulmonary oxygenators market.
South America Cardiopulmonary Oxygenator Market Overview
The South America cardiopulmonary oxygenator market is segmented into Brazil, Argentina, and the Rest of South & Central America. The healthcare facilities and services are better in the country compared to the other countries in the region. It has been experiencing the fastest demographic aging worldwide. In 2020, the geriatric population accounted for 30.1 million, ~14.3% of the total population. Further, as per the Brazil Statistical Institute, people aged 65 and over are expected to reach 36% by 2050. Aging increases vulnerability to various chronic diseases, such as lung disorders, including idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease, which have become more common among older people. As the geriatric population in Brazil grows, it leads to an increased incidence of various health illnesses, such as respiratory diseases, leading to increased demand for respiratory inhalers. The aging population results in increased incidences of diseases. According to Instituto Nacional de Estadística y Censos, INDEC, in 2020, 15.7% of Argentina's population was over age 60, or almost 7.1 million people. And is estimated to continue to rise to 22% by 2050, which will be equivalent to around 12.5 million people, and will reach 34% by 2100, approximately 20 million individuals.Moreover, approximately one-third of the community receives free public health services, and private or institutional insurance healthcare providers cover two-third of the siders. Additionally, the awareness rate for medical diagnosis of acute cardiovascular disease is low, between 50% to 60%. Therefore, an AF Association was started in Argentina that provide information, support, and access to established, new or innovative treatments for Atrial Fibrillation (AF) in the region
South America Cardiopulmonary Oxygenator Market Revenue and Forecast to 2028 (US$ Million)
South America Cardiopulmonary Oxygenator Market Segmentation
The South America cardiopulmonary oxygenator market is segmented into product, application, type, age group, end use, and country. Based on product, the market is bifurcated into membrane oxygenator and bubble oxygenator. The membrane oxygenator segment held a larger market share in 2022.Based on application, the market is bifurcated into cardiac and respiratory. The cardiac segment held a larger market share in 2022. Further, cardiac is segmented into acute myocardial infarction, myocarditis, post-transplant complications, decompensated cardiomyopathy, and others. Further, respiratory is segmented into respiratory failure, acute respiratory distress syndrome, pulmonary embolism, pneumonia, and COVID-19.
Based on type, the market is bifurcated into reusable cardiopulmonary oxygenators and disposable cardiopulmonary oxygenators. The reusable cardiopulmonary oxygenators segment held a larger market share in 2022.
Based on age group, the market is segmented into adults, pediatric, and neonates. The adults segment held the largest market share in 2022.
Based on end use, the market is segmented into hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment held the largest market share in 2022.
Based on country, the market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the market share in 2022.
Getinge AB; LivaNova Plc; Medtronic Plc; Terumo Corp; Nipro Medical Corp; Microport Scientific Corp; Braile Biomedica Industry, Commerce and Representation Ltd; Chalice Medical Ltd; and Fresenius Medical Care AG & Co KGaA are the leading companies operating in the cardiopulmonary oxygenator market in the region.
Table of Contents
1. Introduction
3. Research Methodology
4. South America Cardiopulmonary Oxygenator Market - Market Landscape
5. South America Cardiopulmonary Oxygenators Market - Key Market Dynamics
6. Cardiopulmonary Oxygenators Market - South America Analysis
7. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Product
8. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Application
9. South America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Type
10. South America Cardiopulmonary Oxygenators Market Analysis and Forecast to 2028 - by Age Group
11. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by End Use
12. South America Cardiopulmonary Oxygenators Market - Revenue and Forecast to 2028 - by Country Analysis
13. South America Cardiopulmonary Oxygenators Market-Industry Landscape
14. Company Profiles
15. Appendix
List of Tables
List of Figure
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Getinge AB
- LivaNova Plc
- Medtronic Plc
- Terumo Corp
- Nipro Medical Corp
- Microport Scientific Corp
- Braile Biomedica Industry, Commerce and Representation Ltd
- Chalice Medical Ltd
- Fresenius Medical Care AG & Co KGaA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | July 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 44.13 million |
| Forecasted Market Value ( USD | $ 53.49 million |
| Compound Annual Growth Rate | 3.3% |
